| 000 | 01778 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513183955.0 | ||
| 264 | 0 | _c19990623 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6690422 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVillar-Grimalt, A | |
| 245 | 0 | 0 |
_aA randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cMay 1999 |
||
| 300 |
_a786-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInterferon-beta _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aCandel, M T | |
| 700 | 1 | _aMassuti, B | |
| 700 | 1 | _aLizón, J | |
| 700 | 1 | _aSánchez, B | |
| 700 | 1 | _aFrau, A | |
| 700 | 1 | _aGorostidi, B | |
| 700 | 1 | _aGoedkoop, R | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 80 _gno. 5-6 _gp. 786-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6690422 _zAvailable from publisher's website |
| 999 |
_c10319234 _d10319234 |
||